The invention relates to fluorobenzamide derivatives of the formula ##STR1##

wherein R¹, R², R³ R⁴, R⁵, R⁶ and R⁷ are as defined herein. =, The compounds of the invention are selective monoamine oxidase B inhibitors and therefore they are suitable for the treatment of diseases mediated by monoamine oxidase B, such as Alzheimer's disease or senile dementia.